FDA Inspection
Sanofi-Aventis Deutschland GmbHSanofi-Aventis Deutschland GmbH – FDA Inspection, May 14, 2019
Record Details
This FDA Inspection record concerns Sanofi-Aventis Deutschland GmbH, with an inspection on May 14, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 8ee42dad-b559-446f-9c69-d3ad6a8d8521
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1094836
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Sanofi-Aventis Deutschland GmbH
11| Date | Classification | Office | Project area |
|---|---|---|---|
| January 16, 2025 | Not classified | Office of Inspections and Investigations | |
| March 25, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 3, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 10, 2015 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| June 26, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sanofi-Aventis Deutschland GmbH
- FDA Inspection 1262770 - 2025-01-16
- FDA Inspection 1215824 - 2022-03-25
- FDA Inspection 1006001 - 2017-03-03
- FDA Inspection 952968 - 2015-12-10
- FDA Inspection 933399 - 2015-06-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.